This hypothesis is in agreement with other results reported in melanoma and colorectal cancer cells, showing that Vemurafenib treatment was followed by an increase in AMPK activity and high levels of activated ULK1, which in turn, were correlated with autophagy induction [47,59]. This evidence concerns the gene ULK1 and colorectal cancer.